Saturday 17 October 2026
Export ATR’s income statement to Excel — free account
AptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.
124.51
0.25
+0.20%
Follow ATR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
20.43 | 27.81 | 28.31 | 30.21 | 32.84 | 41.23 | 30.35 | 30.15 | 24.65 | 22.33 |
Piotroski F-Score |
5 | 8 | 7 | 6 | 6 | 5 | 6 | 4 | 5 | 5 |
P/S ratio |
2.12 | 2.91 | 2.31 | 2.17 | 2.49 | 3.01 | 2.57 | 2.12 | 2.20 | 1.97 |
Altman Z-Score |
3.78 | 5.25 | 4.11 | 3.90 | 4.01 | 4.24 | 4.17 | 3.70 | 3.91 | 4.20 |
Altman Z″-Score (non-manufacturers) |
4.29 | 4.44 | 3.74 | 3.92 | 3.53 | 3.79 | 4.05 | 3.90 | 5.19 | 5.00 |
P/FCF ratio |
26.90 | 29.71 | 30.75 | 44.90 | 147.17 | 27.27 | 27.06 | 55.29 | 32.40 | 23.46 |
Beneish M-Score |
(2.48) | (2.77) | (2.80) | (2.75) | (2.43) | (2.86) | (2.84) | (2.27) | (2.52) | (2.49) |
P/Operating CF |
43.65 | 58.47 | 36.71 | 41.86 | 77.28 | 46.72 | 54.82 | 56.45 | 91.20 | 37.32 |
Dividend Safety Score |
92 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.99 | 4.19 | 3.47 | 3.49 | 4.05 | 4.76 | 4.68 | 4.13 | 4.14 | 3.91 |
Price to Tangible BV |
5.93 | 8.05 | 7.50 | 8.94 | 12.41 | 14.50 | 14.20 | 12.88 | 7.03 | 6.82 |
EV/Sales |
2.41 | 3.13 | 2.55 | 2.48 | 2.78 | 3.29 | 2.89 | 2.46 | 2.42 | 2.10 |
EV/EBITDA |
11.53 | 14.76 | 13.63 | 13.44 | 15.40 | 17.22 | 14.59 | 14.85 | 12.53 | 10.45 |
EV/Operating CF |
15.95 | 17.44 | 15.47 | 17.22 | 24.68 | 16.91 | 16.06 | 21.68 | 18.39 | 15.05 |
EV/FCF |
30.50 | 31.99 | 33.93 | 51.31 | 164.11 | 29.81 | 30.40 | 64.01 | 35.63 | 25.05 |
Quick Ratio |
1.04 | 0.83 | 0.72 | 0.89 | 0.81 | 1.11 | 1.17 | 1.21 | 2.32 | 1.66 |
Current Ratio |
1.62 | 1.38 | 1.24 | 1.56 | 1.38 | 1.75 | 1.89 | 1.93 | 3.16 | 2.34 |
Net Debt/EBITDA |
1.36 | 1.05 | 1.28 | 1.68 | 1.59 | 1.47 | 1.61 | 2.02 | 1.13 | 0.66 |
Debt/Assets |
28.23% | 23.16% | 23.76% | 27.87% | 25.34% | 28.09% | 32.32% | 35.19% | 39.93% | 29.82% |
Debt/Equity |
0.55 | 0.41 | 0.46 | 0.57 | 0.53 | 0.61 | 0.73 | 0.84 | 0.96 | 0.66 |
Asset Turnover |
0.78 | 0.81 | 0.81 | 0.80 | 0.79 | 0.78 | 0.82 | 0.85 | 0.86 | 0.92 |
Operating CF/Net income |
1.45 | 1.72 | 2.02 | 2.00 | 1.49 | 2.66 | 2.12 | 1.61 | 1.48 | 1.58 |
Capex/Depreciation |
(0.95) | (1.11) | (1.26) | (1.35) | (1.29) | (1.12) | (1.25) | (1.21) | (1.01) | (0.84) |
Interest Coverage |
9.50 | 11.31 | 10.00 | 9.29 | 11.47 | 10.21 | 10.47 | 8.77 | 7.97 | 8.90 |
| 15.19% | 15.58% | 12.96% | 11.81% | 12.73% | 12.51% | 16.17% | 14.24% | 17.70% | 17.69% | |
| 8.11% | 8.43% | 6.57% | 5.74% | 6.00% | 5.67% | 6.98% | 5.98% | 7.66% | 8.15% | |
ROIC |
8.33% | 9.44% | 8.00% | 7.65% | 7.46% | 7.94% | 9.36% | 7.61% | 10.91% | 13.20% |
Return on Tangible Assets |
16.34% | 20.17% | 16.02% | 12.89% | 14.78% | 11.97% | 14.28% | 11.92% | 10.95% | 13.60% |
Average Days of Receivables |
77.68 | 67.04 | 70.94 | 74.38 | 75.93 | 70.60 | 71.27 | 75.20 | 75.45 | 67.82 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
16.06% | 16.25% | 16.22% | 16.38% | 17.08% | 17.08% | 15.90% | 15.55% | 15.69% | 15.71% |
Intangible Assets out of Total Assets |
0.25 | 0.27 | 0.28 | 0.30 | 0.32 | 0.31 | 0.30 | 0.29 | 0.17 | 0.19 |
Share Based Compensation of Revenue |
1.16% | 1.33% | 1.18% | 1.23% | 1.20% | 1.17% | 0.84% | 0.71% | 0.77% | 0.85% |
Graham Net Nets |
(0.08) | (0.04) | (0.07) | (0.10) | (0.10) | (0.09) | (0.09) | (0.11) | (0.03) | (0.04) |
Graham Number |
74.08 | 69.02 | 58.78 | 50.96 | 50.36 | 46.33 | 46.04 | 40.00 | 40.85 | 37.09 |
Earnings Yield |
4.90% | 3.60% | 3.53% | 3.31% | 3.05% | 2.43% | 3.30% | 3.32% | 4.06% | 4.48% |
Free Cash Flow Yield |
3.72% | 3.37% | 3.25% | 2.23% | 0.68% | 3.67% | 3.70% | 1.81% | 3.09% | 4.26% |
Revenue per Share |
57.46 | 54.01 | 53.15 | 50.80 | 49.15 | 45.47 | 44.98 | 44.28 | 39.55 | 37.11 |
Operating CF per Share |
8.67 | 9.70 | 8.77 | 7.32 | 5.54 | 8.85 | 8.09 | 5.02 | 5.20 | 5.18 |
Capex per Share |
(4.14) | (4.41) | (4.77) | (4.82) | (4.61) | (3.83) | (3.82) | (3.32) | (2.48) | (2.07) |
Free Cash Flow per Share |
4.53 | 5.29 | 4.00 | 2.49 | 0.93 | 5.02 | 4.27 | 1.70 | 2.73 | 3.11 |
Cash per Share |
6.23 | 3.41 | 3.41 | 2.17 | 1.88 | 4.66 | 3.81 | 4.19 | 11.41 | 7.42 |
Shareholders Equity per Share |
40.86 | 37.48 | 35.38 | 31.62 | 30.22 | 28.73 | 24.73 | 22.79 | 21.01 | 18.70 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
40.86 | 37.48 | 35.38 | 31.62 | 30.22 | 28.73 | 24.73 | 22.79 | 21.01 | 18.70 |
Free Cash Flow |
298.11 | 350.73 | 262.18 | 163.09 | 60.74 | 323.37 | 271.68 | 106.23 | 170.14 | 195.51 |
Working Capital |
727.12 | 410.10 | 297.97 | 513.12 | 375.72 | 588.67 | 607.97 | 641.64 | 1,142.33 | 727.22 |
Capital Expenditures |
(271.89) | (292.68) | (313.05) | (315.52) | (302.70) | (246.78) | (242.78) | (207.40) | (154.59) | (129.78) |
Net Current Asset Value |
(673.18) | (467.97) | (581.31) | (704.96) | (798.56) | (770.27) | (698.63) | (624.06) | (155.70) | (162.37) |
EV/EBIT |
18.14 | 22.60 | 22.02 | 21.73 | 25.82 | 28.39 | 22.22 | 23.75 | 18.46 | 15.61 |
Capex to Sales |
0.07 | 0.08 | 0.09 | 0.10 | 0.09 | 0.08 | 0.08 | 0.08 | 0.06 | 0.06 |
Price to Operating Income |
16.00 | 20.99 | 19.96 | 19.01 | 23.15 | 25.97 | 19.78 | 20.52 | 16.79 | 14.62 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.17 | 0.18 | 0.17 | 0.17 | 0.18 | 0.18 | 0.18 | 0.17 | 0.18 | 0.20 |
Cash ROIC |
6.51% | 9.38% | 7.28% | 4.82% | 1.92% | 9.88% | 9.16% | 3.70% | 5.19% | 8.09% |
Accounts Receivable Turnover |
5.17 | 5.36 | 5.15 | 4.93 | 5.21 | 5.21 | 5.07 | 5.12 | 5.23 | 5.65 |
Accounts Payable Turnover |
3.06 | 2.92 | 2.80 | 2.90 | 3.06 | 2.98 | 3.31 | 3.67 | 3.86 | 4.13 |
Inventory Turnover |
4.75 | 4.57 | 4.45 | 4.65 | 5.04 | 4.88 | 4.80 | 5.05 | 5.06 | 5.06 |
Average Days of Payables |
126.60 | 119.62 | 130.16 | 134.34 | 122.14 | 131.21 | 115.02 | 105.74 | 105.10 | 90.05 |
Days of Inventory on Hand |
82.75 | 75.68 | 84.20 | 82.32 | 77.82 | 75.14 | 75.43 | 76.73 | 76.78 | 72.43 |
Average Receivables |
730.94 | 667.94 | 677.40 | 674.17 | 618.99 | 562.53 | 564.03 | 540.03 | 471.78 | 412.35 |
Average Payables |
776.45 | 761.54 | 793.74 | 743.63 | 677.66 | 617.75 | 549.11 | 493.39 | 415.36 | 362.03 |
Average Inventory |
499.83 | 487.43 | 499.93 | 464.14 | 410.42 | 377.59 | 378.45 | 359.16 | 317.07 | 295.91 |
Average Assets |
4,842.50 | 4,442.08 | 4,327.67 | 4,172.41 | 4,065.71 | 3,776.09 | 3,469.93 | 3,257.78 | 2,872.30 | 2,521.92 |
Average Common Equity |
2,585.95 | 2,403.61 | 2,194.75 | 2,026.40 | 1,917.69 | 1,711.52 | 1,497.56 | 1,367.46 | 1,243.15 | 1,161.97 |
Columns are period end dates